An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

The FDA panel voted against Otsuka's PTSD drug combination with Zoloft, questioning its efficacy. Getinge surpassed profit ...

Otsuka and Lundbeck’s data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD, according ...

The FDA panel rejects Otsuka's PTSD drug combination. Humana's lawsuit challenging Medicare rating downgrades is dismissed. Spain reports an avian flu outbreak, causing global supply concerns.

The controversial drugs are not yet approved by federal regulators, butadvocates hope a NC law would allow the state to be ...

The administration said it is fast-tracking clinical trials that would allow patients struggling with serious mental health ...

The head of the U.S. Department of Veterans Affairs (VA) is reiterating that he’s “very open” to expanding access to ...

Market is valued at USD 10.25 Billion in 2024 and is projected to reach a value of USD 610.1 Billion by 2035 at a CAGR ...

Proponents of reining in the largely unregulated intoxicating hemp industry in Texas shared new polling data on Wednesday ...

July marks National Minority Mental Health Awareness Month. Black and brown communities often can face specific mental health ...

Boosting the body’s well-being sometimes feels complicated, but some powerful solutions are right inside everyone.

The prospect of Lundbeck and Otsuka’s Rexulti becoming part of a new treatment for post-traumatic stress disorder (PTSD) ...